Literature DB >> 27910033

Cytogenetic Resources and Information.

Etienne De Braekeleer1, Jean-Loup Huret2, Hossain Mossafa3, Philippe Dessen4.   

Abstract

The main databases devoted stricto sensu to cancer cytogenetics are the "Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer" ( http://cgap.nci.nih.gov/Chromosomes/Mitelman ), the "Atlas of Genetics and Cytogenetics in Oncology and Haematology" ( http://atlasgeneticsoncology.org ), and COSMIC ( http://cancer.sanger.ac.uk/cosmic ).However, being a complex multistep process, cancer cytogenetics are broadened to "cytogenomics," with complementary resources on: general databases (nucleic acid and protein sequences databases; cartography browsers: GenBank, RefSeq, UCSC, Ensembl, UniProtKB, and Entrez Gene), cancer genomic portals associated with recent international integrated programs, such as TCGA or ICGC, other fusion genes databases, array CGH databases, copy number variation databases, and mutation databases. Other resources such as the International System for Human Cytogenomic Nomenclature (ISCN), the International Classification of Diseases for Oncology (ICD-O), and the Human Gene Nomenclature Database (HGNC) allow a common language.Data within the scientific/medical community should be freely available. However, most of the institutional stakeholders are now gradually disengaging, and well-known databases are forced to beg or to disappear (which may happen!).

Entities:  

Keywords:  Atlas of Genetics and Cytogenetics in Oncology and Haematology; COSMIC; Cancer; Cytogenetic; Database; Ensembl; HGNC; ICD-O; Mitelman database; UCSC

Mesh:

Year:  2017        PMID: 27910033     DOI: 10.1007/978-1-4939-6703-2_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Quantitative proteomic and phosphoproteomic comparison of human colon cancer DLD-1 cells differing in ploidy and chromosome stability.

Authors:  Cristina Viganó; Conrad von Schubert; Erik Ahrné; Alexander Schmidt; Thomas Lorber; Lukas Bubendorf; Judith R F De Vetter; Guido J R Zaman; Zuzana Storchova; Erich A Nigg
Journal:  Mol Biol Cell       Date:  2018-05-01       Impact factor: 4.138

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.